Bronchitis often has a close relationship with viral and bacterial infections and recurrent infections. The treatment can choose Bolekangni atomizing liquid, which can relax the bronchial smooth muscle, improve edema, and is effective for bronchial asthma, chronic bronchitis, emphysema, and other bronchospastic lung diseases. Then, what are the side effects of Bolekangni atomizing liquid? Many people are also worried about this issue. What are the effects of Bolekangni atomizing liquid?

The generic name of Bolekangni atomizing liquid is Terbutaline Hydrochloride Atomizing Solution, which is a selective stimulatory b2-adenylate cyclase inhibitor. After being digested, absorbed, and utilized by the body, it can relax the bronchial smooth muscle, inhibit the release of endogenous spasmogens, and can also reduce swelling. Bolekangni atomizing liquid has a fast onset of action and can maintain its effect for 6 hours. It is within the scope of treatment for bronchial asthma, chronic bronchitis, emphysema, and other bronchospastic lung diseases. It can also be used as a maintenance treatment for severe obstructive lung diseases.

What are the side effects of Bolekangni atomizing liquid?

The side effects of Bolekangni atomizing liquid are mainly the characteristics of central nervous system amine, such as tremors and mild palpitations. However, these symptoms usually disappear after taking the medication for one to two weeks. Persistent individualized medication, and according to the electronic nebulizer, adults and children over 25kg can inhale 1 bottle (5mg, 2ml) of the drug solution up to 3 times a day. For younger children, the dosage should be reduced according to the specialist’s instructions.

When using the Bolekangni atomizing liquid, attention should be paid to the dosage based on the patient’s age and body weight, and it must not exceed the recommended dosage to avoid adverse effects on the human body. Follow the doctor’s instructions, and take immediate effective measures for rescue if any abnormalities occur.